Showing results (31-40 of 248) with videos related to

Sort By:
Pageof 25
Oncoimmunology|July 3, 2015
Protective role of STING against gliomagenesis: Rational use of STING agonist in anti-glioma immunotherapyTakayuki Ohkuri, Arundhati Ghosh, Akemi Kosaka, et al.
Expert Review of Neurotherapeutics|October 15, 2013
Ependymomas: development of immunotherapeutic strategiesIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Current Opinion in Oncology|July 20, 2022
Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant gliomaPayal B Watchmaker, Maggie Colton, Psalm L Pineo-Cavanaugh, et al.
Acta Neurochirurgica|March 12, 2017
Endoscopic approach via the interhemispheric fissure: the role of an endoscope in a surgical case of multiple falcine lesionsJunya Yamaguchi, Tadashi Watanabe, Tetsuya Nagatani
Frontiers in Immunology|February 12, 2019
Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective ImmunotherapyPavlina Chuntova, Kira M Downey, Bindu Hegde, et al.
Seminars in Immunology|February 11, 2020
Tumor antigens in gliomaTakahide Nejo, Akane Yamamichi, Neil D Almeida, et al.
Ebiomedicine|January 6, 2024
Glioblastoma vaccines: past, present, and opportunitiesZujian Xiong, Itay Raphael, Michael Olin, et al.
World Neurosurgery|January 25, 2019
Immunotherapy for High-Grade Gliomas: A Clinical Update and Practical Considerations for NeurosurgeonsJacob S Young, Fara Dayani, Ramin A Morshed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chainFumiyoshi Okano, Walter J Storkus, William H Chambers, et al.
Pageof 25